Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Science (New York, N.Y.)|January 6, 1984
Purification and sequence analysis of bioactive atrial peptides (atriopeptins)M G Currie, D M Geller, B R Cole, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistributionD R Johnson, A D Cox, P A Solski, et al.
The Journal of Biological Chemistry|April 15, 1992
Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replicationB Devadas, T Lu, A Katoh, et al.
The Journal of Biological Chemistry|May 15, 1991
The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residueN S Kishore, T B Lu, L J Knoll, et al.
Biochemical and Biophysical Research Communications|April 30, 1984
Atriopeptins: a family of potent biologically active peptides derived from mammalian atriaD M Geller, M G Currie, K Wakitani, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheepW M Abraham, A Gill, A Ahmed, et al.
FEBS Letters|November 30, 1987
Phosphorylation of high- and low-molecular-mass atrial natriuretic peptide analogs by cyclic AMP-dependent protein kinaseG M Olins, P P Mehta, D J Blehm, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Expression of bacterial genes in plant cellsR T Fraley, S G Rogers, R B Horsch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2004
Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical propertiesR B Pepinsky, W-C Lee, M Cornebise, et al.
Pageof 9